“The World Health Organization Prequalification of Swiss Pharma Nigeria Limited's SP tablet will go a long way in reaching tens of millions of pregnant women in Nigeria to prevent malaria, thanks to USAID and US Pharmacopeia support.” ?? Abbas Sambo | Swipha Business Development and Licensing Director Recently, with the support of USAID-funded PQM+ program, Nigeria-based manufacturer received prequalification for an essential medicine that prevents malaria in pregnant women and India-based Mepro Pharmaceuticals Pvt. Ltd. was approved for a product to treat intestinal parasites. USP is proud to have supported these manufacturers to attain WHO PQs and help expand the supply of safe, effective, and quality-assured medicines. Visit our newsroom to learn more about this win for patient safety: Ow.ly/ZJh250Tl0Jx #GlobalHealth #Africa #SupplyChain #QualityMonth
